Skip to main content
RAPS Euro Convergence 2026 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Learning Level: Advanced
Learning Level: Advanced
Learning Level: Expert
Learning Level: Expert
Learning Level: Foundational
Learning Level: Foundational
Learning Level: Intermediate
Learning Level: Intermediate
RAPS Focus
RAPS Focus
Networking Opportunity
Networking Opportunity
Ticketed Event
Ticketed Event
Student Focus
Student Focus

Michelle Kelly, ERT (she/her/hers)

Toxicologist
NAMSA

Michelle Kelly is chair of CH/194 – Biological evaluation of medical device, a committee responsible for the UK input to ISO/TC 194 and CEN/TC 206 for standards relating to biological and clinical evaluation of medical devices. She has worked as a consultant with NAMSA for 4 years, a leading global medical device contract research organisation providing medical device manufacturers with the support they need in navigating the complexities of medical device development. Prior to this role, Michelle worked as biological safety manager for the Medicines and Healthcare products Regulatory Agency (MHRA), the UK Competent Authority. In addition, she is a European Registered Toxicologist (ERT).

Presentation(s):